Article (Scientific journals)
Does glucose-6-phosphate dehydrogenase deficiency worsen the clinical features of sickle cell disease? A multi-hospital-based cross-sectional study.
Kambale-Kombi, Paul; Marini Djang'Eing'A, Roland; Alworong'a Opara, Jean-Pierre et al.
2022In Hematology (Amsterdam, Netherlands), 27 (1), p. 590-595
Peer Reviewed verified by ORBi
 

Files


Full Text
Does glucose 6 phosphate dehydrogenase deficiency worsen the clinical features of sickle cell disease A multi hospital based cross sectional study.pdf
Author postprint (1.15 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Democratic Republic of the Congo; G-6-PD deficiency; Sickle cell disease; clinical features; comorbidity; prevalence; red blood cell disorders; sub-Saharan Africa; Cross-Sectional Studies; Hospitals; Humans; Prospective Studies; Anemia, Sickle Cell/complications; Anemia, Sickle Cell/epidemiology; Glucosephosphate Dehydrogenase Deficiency/complications; Glucosephosphate Dehydrogenase Deficiency/epidemiology; Hematology
Abstract :
[en] BACKGROUND: The impact of glucose-6-phosphate dehydrogenase deficiency(G-6-PD) on the clinical course of sickle cell disease(SCD) is still controversial. The objectives of this study were to determine the prevalence of G-6-PD deficiency in patients with SCD and its effect on their clinical course. METHODS: A cross-sectional study of 122 SCD patients and 211 healthy blood donors was conducted in Kisangani city. Data were collected through clinical examination supplemented by patient medical records, and laboratory tests based on a survey form. G-6-PD activity was measured by spectrophotometry and the screening for SCD by the HemoTypeSC® rapid test. Statistical analysis was done using SPSS ver. 20.0. RESULTS: The prevalence of G-6-PD deficiency did not differ between SCD and non-SCD subjects, 35.2% vs. 33.6% respectively(p = .767). When comparing the hemoglobin level between SCD patients with and without G-6-PD deficiency, no significant difference was observed. However, in the 6 months prior to the study, SCD patients with G-6-PD deficiency had on average more transfusions than non-deficient SCD patients, 0.64 ± 0.897 vs. 0.24 ± 0.486(p = .004). Similarly, considering the clinical events of the last 12 months prior to the study, there were more hospitalizations, major vaso-occlusive crises and anemia requiring blood transfusion among G-6-PD deficient SCD patients compared to no-deficient, respectively 1.42 ± 1.451vs. 0.76 ± 1.112(p = .007); 1.37 ± 1.092 vs. 0.85 ± 1.014(p = .005); 0.74 ± 0.902 vs. 0.38 ± 0.739 (p = .007). CONCLUSION: The prevalence of G-6-PD deficiency in SCD patients was high but did not differ from that observed in controls. In addition, G-6-PD deficiency appeared to worsen the clinical features of SCD. Nevertheless, prospective studies further clarifying this observation are needed.
Disciplines :
Genetics & genetic processes
Author, co-author :
Kambale-Kombi, Paul ;  Department of Internal Medicine, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
Marini Djang'Eing'A, Roland ;  Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM) ; Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
Alworong'a Opara, Jean-Pierre;  Department of Pediatrics, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
Minon, Jean-Marc;  Department of Laboratory Medicine, Transfusion and Thrombosis-Haemostasis Unit, Centre Hospitalier Régional de la Citadelle, Liège, Belgium
Atoba Bokele, Camille;  Department of Internal Medicine, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
BOURS, Vincent ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique
Azerad, Marie-Agnès;  Department of Haematology, CHU of Liège at Site CHR Citadelle, Liège, Belgium
Tonen-Wolyec, Serge ;  Department of Internal Medicine, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
Kayembe Tshilumba, Charles;  Department of Internal Medicine, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
Batina-Agasa, Salomon;  Department of Internal Medicine, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
Language :
English
Title :
Does glucose-6-phosphate dehydrogenase deficiency worsen the clinical features of sickle cell disease? A multi-hospital-based cross-sectional study.
Publication date :
December 2022
Journal title :
Hematology (Amsterdam, Netherlands)
ISSN :
1024-5332
eISSN :
1607-8454
Publisher :
Informa UK Limited, England
Volume :
27
Issue :
1
Pages :
590-595
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 06 July 2022

Statistics


Number of views
111 (6 by ULiège)
Number of downloads
48 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi